Lowell Farms Inc. Announces Unaudited First Quarter 2024 Financial and Operational Results
SALINAS, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- *Lowell Farms Inc.* (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California cannabis company with advanced distribution and production capabilities including extraction, manufacturing, sales and brand management, announces unaudited revenue and operating results for the first quarter of 2024 (ended March 31, 2024). All figures stated are in US Dollars.*First Quarter Financial Highlights:*
· *Net revenue* generated for the quarter ended March 31, 2024 decreased 35% to $4.9 million, as compared to $7.5 million for the first quarter last year. Net revenue increased 35% from $7.5 million in the fourth quarter of 2023.
· *CPG* *revenue* decreased 11% for the quarter ended March 31, 2024 compared to the quarter ended March 31, 2023 and increased 10% compared to the fourth quarter of 2023.
· *Bulk Product* *revenue* from self-grown wholesale products decreased 73% for the quarter ended March 31, 2024 compared to the quarter ended March 31, 2023 and decreased 66% compared to the fourth quarter of 2023.
· *LFS* *revenue* from drying, curing and trimming cannabis plants decreased 41% for the quarter ended March 31, 2024 compared to the quarter ended March 31, 2023 and decreased 93% compared to the fourth quarter of 2024.
· *Gross margin* for the quarter ended March 31, 2024 was negative 17% representing a gross loss of $0.8 million and adversely impacted by exiting the cultivation facility.
· *Operating loss* for the quarter ended March 31, 2024 was $2.9 million, compared to operating loss of $2.4 million for the quarter ended March 31, 2023 and $9.6 compared to the fourth quarter of 2023.
· *Net loss* was $2.9 million for the quarter ended March 31, 2024, compared to a net loss of $4.0 million for the quarter ended March 31, 2023, and a net loss of $13.1 million for the fourth quarter of 2023.
· *Adjusted EBITDA* for the quarter ended March 31, 2024 was negative $1.1 million compared to adjusted EBITDA of negative $1.1 million for the quarter ended March 31, 2023 and adjusted EBITDA of negative $4.1 million for the fourth quarter of 2023. Adjusted EBITDA is a non-GAAP financial measure. See “Use of Non-GAAP Financial Information'' below for further information and a detailed reconciliation to Net Loss, the closest comparable GAAP measure.
*Revenue Summary ($’s in ‘000)*
Q1’24 vs Q4’23 *Q1’23* *Q4’23* *Q1’24* *Growth*
CPG Revenues $4,659 $4,582 $4,125 -10%
Bulk Product $2,530 $1,984 $681 -66%
LFS $115 $918 $68 -93%
Out-of-State Licensing $222 $11 - -100%
Total $7,526 $7,495 $4,874 -35%
“Our recent strategic decisions have thoughtfully bolstered our manufacturing and distribution capabilities, allowing us to navigate the ever evolving industry landscape. By optimizing efficiencies, we’re poised for steady growth and positive impact.” said Co-Founder and Chief Executive Officer Mark Ainsworth. “Our team remains committed to the strategic shifts the company has made in the previous quarters and we expect to see meaningful change.”
*Operational Highlights and Ongoing Initiatives: *
· *Lowell Farm Services*
· Lowell Farms processing facility in Salinas Valley.
· In the first quarter of 2024 the Company generated revenue of approximately $0.1 million associated with Lowell Farm Services in comparison to $0.9 million in the fourth quarter of 2023.
· Lowell Farm Services processed approximately 6,173 pounds of wet weight third-party flower in the first quarter or 2024 compared to 116,762 pounds in the fourth quarter of 2023.
· This decrease quarter over quarter was largely due to the company's exit of the cultivation in January of 2024.
· *California Market Trends*
· Owned and Portfolio Brands
· Sales of owned brands generated revenue of $3.1 million in the first quarter of 2024, compared to approximately $3.7 million for the fourth quarter of 2023.
· Contributing factors include significant decrease in California market purchasing trends and instability in flower purchase price.
· Lowell Herb Co.
· The Lowell Herb Co. branded 35's product line remained stable quarter over quarter maintaining robust sales at just over $900k for the first quarter of 2024.
· The Infused 35’s products showed notable growth, registering an increase quarter over quarter to reach sales of approximately $170k in the first quarter of 2024 compared to approximately $120k in the fourth quarter of 2023.
· Moon and Original Pot Co., two edible brands in the owned portfolio have since been active in the first quarter of 2024 and regaining shelf space within the California marketplace.
· Third-Party Brands
· The Company re-engaged the third-party brand model strategy and pursued like minded brands to increase revenues and maximize operational efficiency.
· Sales of third-party brands generated revenue of approximately $952k for the first quarter of 2024 compared to $955k in the fourth quarter of 2023.
· By the end of the first quarter of 2024, Lowell had brought on over 20 additional third-party brands to round the offerings to dispensary partners.
· *Distribution and Sales Capabilities:*
· The average delivery drop value has increased to approximately $4,082 in the first quarter of 2024 from $3,809 in the fourth quarter of 2023.
*Q1 2024 Financial Results Earnings Conference Call Details:*
The conference call with management at 5:30 p.m. EDT on Tuesday, May 14, can be accessed using the following dial-in information:
U.S. and Canadian Toll Free: 1-800-267-6316
International: 1-203-518-9783
Webcast: Link here
Please dial-in at least 10 minutes before the call to register.
The conference call will be webcast live and archived on the investor relations section of the Lowell Farms website at https://ir.lowellfarms.com/.
*ABOUT LOWELL FARMS INC.*
Lowell Farms Inc. (CSE:LOWL; OTCQX:LOWLF) (the “Company”) is a California-based cannabis company with advanced production capabilities supporting the supply chain, including extraction, manufacturing, brand sales, marketing, and distribution. Lowell Farms has an exclusive portfolio of award-winning brands, including Lowell Herb Co, House Weed, Moon, Cypress Cannabis, and Original Pot Co. for licensed retailers statewide.
*Lowell Farms Inc. Media Contact*
pr@lowellfarms.com
*Lowell Farms Inc. Investor Relations Contact*
Bill Mitoulas
416.479.9547
ir@lowellfarms.com
*Lowell Farms Inc. Company Contact*
Mark Ainsworth
ir@lowellfarms.com
*Forward-Looking Information and Statements*
This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current conditions, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved.” The forward-looking information and forward-looking statements contained herein may include, but are not limited to, the anticipated growth of Lowell Farm Services and the ability of the Company to successfully achieve its business objectives and expectations for other economic, business, and/or competitive factors. There can be no assurance that such forward-looking information and statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such forward-looking information and statements. This forward-looking information and statements reflect the Company’s current beliefs and are based on information currently available to the Company and on assumptions the Company believes are reasonable.
Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information. Such risks and other factors may include, but are not limited to: general business, economic, competitive, political and social uncertainties; general capital market conditions and market prices for securities; operating and development costs; competition; changes in legislation or regulations affecting the Company; the timing and availability of external financing on acceptable terms; the available funds of the Company and the anticipated use of such funds; favorable production levels and outputs; the stability of pricing of cannabis products; the level of demand for cannabis product; the availability of third-party service providers and other inputs for the Company’s operations; lack of qualified, skilled labor or loss of key individuals; and risks and delays resulting from the COVID-19 pandemic. A description of additional assumptions used to develop such forward-looking information and a description of additional risk factors that may cause actual results to differ materially from forward-looking information can be found in the Company’s disclosure documents, such as the Company’s annual information form filed on the SEDAR website at www.sedar.com and the Company's Form 10 filed on the SEC website at www.sec.com. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. Readers are cautioned that the foregoing list of factors is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking information as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Forward-looking information contained in this news release is expressly qualified by this cautionary statement.
The forward-looking information contained in this news release represents the expectations of the Company as of the date of this news release and, accordingly, is subject to change after such date. However, the Company expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.
Neither the Canadian Securities Exchange nor its Regulation Service Provider has reviewed, or accepts responsibility for the adequacy or accuracy of, the content of this news release.
Use of Non-GAAP Financial Information
EBITDA is net income (loss), excluding the effects of income taxes (recovery); net interest expense; depreciation and amortization; and adjusted EBITDA also includes noncash fair value adjustments on investments; unrealized foreign currency gains/losses; share-based compensation expense; and other transactional and special expenses, such as out-of-period insurance recoveries and acquisition costs and expenses related to the markup of acquired finished goods inventory, which are inconsistent in amount and frequency and are not what we consider as typical of our continuing operations. Management believes this measure provides useful information as it is a commonly used measure in the capital markets and as it is a close proxy for repeatable cash generated by operations. We use adjusted EBITDA internally to understand, manage, make operating decisions related to cash flow generated from operations and evaluate our business. In addition, we use adjusted EBITDA to help plan and forecast future periods.
This measure is not necessarily comparable to similarly titled measures used by other companies.
A reconciliation of this measure to Net Loss is provided below.
*LOWELL FARMS INC.*
*CONDENSED CONSOLIDATED BALANCE SHEETS*
*(unaudited)*
*(in thousands)* *March 31,* *December 31,* *2024* *2023*
*ASSETS*
Current assets:
Cash and cash equivalents $ 1,175 $ 2,311
Accounts receivable - net of allowance for doubtful accounts of $1,149 and $959 at March 31, 2024 and December 31, 2023, respectively. 2,067 2,620
Inventory 4,224 4,760
Prepaid expenses and other current assets 2,253 2,397
*Total current assets* *9,719* *12,088*
Property and equipment, net 3,814 4,099
Right of use assets, net 17,900 18,327
Other intangibles, net 2,448 2,544
Other assets 465 555
*Total assets* *$* *34,346* *$* *37,613*
*LIABILITIES AND STOCKHOLDERS’ EQUITY*
Current liabilities:
Accounts payable $ 3,931 $ 4,314
Accrued payroll and benefits 212 363
Notes payable, current portion 2 3
Lease obligation, current portion 1,932 1,990
Other current liabilities 2,493 1,943
*Total current liabilities* *8,570* *8,613*
Lease obligation 17,161 17,522
*Total liabilities* *25,731* *26,135*
COMMITMENTS AND CONTINGENCIES
*STOCKHOLDERS’ EQUITY*
Share capital 192,471 192,445
Accumulated deficit (183,856 ) (180,967 )
*Total stockholders’ equity* *8,615* *11,478*
*Total liabilities and stockholders’ equity* *$* *34,346* *$* *37,613*
*See Accompanying Notes to Condensed Consolidated Financial Statements (unaudited)*
*LOWELL FARMS INC.*
*CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)*
*(unaudited)*
*(in thousands, except per share amounts)* *Three Months Ended* *March 31,* *March 31,* *2024* *2023*
Net revenue $ 4,874 $ 7,526
Cost of goods sold 5,701 7,394
Gross profit (loss) (827 ) 132
Operating expenses
General and administrative 1,553 1,673
Sales and marketing 408 735
Depreciation and amortization 98 106
Total operating expenses 2,059 2,514
Loss from operations (2,886 ) (2,382 )
Other income/(expense)
Other income (expense) 6 1
Unrealized change in fair value of investment - -
Interest expense (9 ) (1,659 )
Total other income (expense) (3 ) (1,658 )
Loss before provision for income taxes (2,889 ) (4,040 )
Provision for income taxes - -
*Net loss* *$* *(2,889* ) *$* *(4,040* *)*
Net loss per share:
Basic $ (0.15 ) $ (0.33 )
Diluted $ (0.15 ) $ (0.33 )
Weighted average shares outstanding:
Basic 19,024 12,177
Diluted 19,024 12,177
*See Accompanying Notes to Condensed Consolidated Financial Statements (unaudited)* *LOWELL FARMS INC.*
*CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS*
*(unaudited)*
*(in thousands)* *Three Months Ended* *March 31,* *March 31,* *2024* *2023*
*CASH FLOW FROM OPERATING ACTIVITIES*
Net loss $ (2,889 ) $ (4,040 )
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization 808 1,196
Amortization of debt issuance costs - 249
Share-based compensation expense 26 60
Provision for doubtful accounts 197 88
Unrealized loss on change in fair value of investments - -
Changes in operating assets and liabilities:
Accounts receivable 356 1,237
Inventory 536 695
Prepaid expenses and other current assets 144 315
Other assets 90 1
Accounts payable and accrued expenses 16 1,111
Operating lease payments (309 ) -
*Net cash provided by (used in) operating activities* *$* *(1,025* *)* *$* *912*
*CASH FLOW FROM INVESTING ACTIVITIES*
Purchases of property and equipment - (29 )
*Net cash used in investing activities* *$* - *$* *(29* *)*
*CASH FLOW FROM FINANCING ACTIVITIES*
Principal payments on lease obligations (110 ) (608 )
Payments on notes payable (1 ) (79 )
*Net cash used in financing activities* *$* *(111* *)* *$* *(687* *)*
Change in cash and cash equivalents (1,136 ) 196
Cash and cash equivalents-beginning of year 2,311 1,098
*Cash, cash equivalents -end of period* *$* *1,175* *$* *1,294*
*SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION*
Cash paid during the period for interest $ 9 $ 821
*OTHER NONCASH INVESTING AND FINANCING ACTIVITIES*
Purchase of property and equipment not yet paid for $ - $ 8
*See Accompanying Notes to Condensed Consolidated Financial Statements (unaudited)*The table below reconciles Net loss to Adjusted EBITDA for the periods indicated: *Three Months Ended* *March 31,* *March 31,*
(in thousands) *2024* *2023*
*Net loss* *$* *(2,889* *)* *$* *(4,040* *)*
Interest expense 9 1,659
Provision for income taxes - 49
Depreciation and amortization in cost of goods sold ^(2) 1,191 1,090
Depreciation and amortization in operating expenses ^(2) 103 106
Depreciation and amortization in other income (expense) - -
*EBITDA*^(1) *(1,586* *)* *(1,136* *)*
Investment and currency (gains)/ losses - -
Share-based compensation 26 60
Transaction and other special charges^(3) 478 -
*Adjusted EBITDA*^(1) *$* *(1,082* *)* *$* *(1,076* *)*
(1) Non-GAAP measure
(2) For the three months ended March 31, 2024, includes $479 related to interest charges on operating leases recorded in cost of goods sold, and $4 related to interest charges on operating leases recorded in operating expenses.
(3) For the three months ended March 31, 2024, includes $478 related to expenses incurred in existing the cultivation facility.